Susquehanna Portfolio Strategies »

Iovance Biotherapeutics shares owned by Susquehanna Portfolio Strategies

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Susquehanna Portfolio Strategies from 13F filings

Historical chart of Susquehanna Portfolio Strategies investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Susquehanna Portfolio Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Susquehanna Portfolio Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.0M 912k 2.17

More positions owned by Susquehanna Portfolio Strategies

Oracle Corporation (ORCL)
Apple (AAPL)
Blackrock (BLK)
Merck & Co (MRK)
Arista Networks Com Shs (ANET)
Pfizer (PFE)
Amazon (AMZN)
Simon Property (SPG)
Baker Hughes Company Cl A (BKR)
Realty Income (O)
American Express Company (AXP)
Chipotle Mexican Grill (CMG)
Vulcan Materials Company (VMC)
General Motors Company (GM)
MetLife (MET)

View all positions for Susquehanna Portfolio Strategies

Top funds holding Iovance Biotherapeutics

MHR Fund Management
BlackRock
Vanguard Group
State Street Corporation
Invenomic Capital Management
Long Focus Capital Management
Palo Alto Investors
Geode Capital Management
Goldman Sachs Group
Morgan Stanley
Susquehanna International
Citadel Advisors
Millennium Management
Principal Financial Group
Dimensional Fund Advisors

View all funds holding Iovance Biotherapeutics